Risk Management & Pharmacovigilance

UBC provides expertise on pre- and postapproval risk management strategies
UBC - January 21, 2014
Once a medical product is taken out of a highly controlled clinical environment and is made available through physicians to their patients, additional risks and unknown safety issues may become apparent. Therefore, proactive risk...
UBC - January 17, 2014
Dr. Annette Stemhagen,  Senior Vice President, Safety, Epidemiology, Registries and Risk Management, and Dr. Robert Sharrar, Executive Director, Safety, Epidemiology, Registries and Risk Management, led an informative tutorial on...
UBC - January 02, 2014
With  40+conferences spanning all service lines and more than 20 UBC experts slated to present in cities across North America and Europe, we have a lot to look forward to in 2014. In order to help you set your calendar for the...
UBC - December 17, 2013
The past twelve months have brought change, and with it, new opportunity. In our last blog post of 2013, we want to take a moment to reflect on our accomplishments and share with our readers some highlights from this past year:...
UBC - December 06, 2013
In order for biopharmaceutical companies to gain product approval, regulatory agencies first require a series of risk evaluations. Clinical trials, for example, may be utilized in the early phases of development in order to prove a...

Pages